Corporate Banner
Satellite Banner
Biomolecular Screening
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Joining the Digital Age

Published: Thursday, February 21, 2013
Last Updated: Thursday, February 21, 2013
Bookmark and Share
TES Pharma has recently purchased an HP D300 Digital Dispenser, and is now reaping the benefits of direct titration with improved assay reproducibility and more time to perform exploratory research.

TES Pharma is a small biotechnology company based in Corciano near Perugia, Italy, specializing in compound screening for pharmaceutical drug discovery. Combining an in depth knowledge of drug design and chemistry with systems and molecular biology approaches, the Company works collaboratively with partners around the world to combine the best aspects of academia and commercial pharmaceutical development.

TES Pharma’s small yet highly skilled and experienced team works closely with the University of Perugia to rapidly develop and explore novel compounds which may be of interest in various disease states. To standardize the Company’s workflow, as well as to free up more staff time for research activities, TES Pharma has recently invested in an HP D300 Digital Dispenser from Tecan. Graeme Robertson, a co-founder of TES Pharma, explained: “The drug discovery process is becoming increasingly highly specialized, often involving multiple partners with distinct skill sets working together to deliver novel therapeutic agents. Our core competence at TES Pharma lies in the development of advanced screening assays, and we believe that, by working closely with academic partners with expertise in individual conditions or disease areas, we can eliminate some of the drawbacks inherent in traditional drug discovery pipelines.”

“To do this we need to concentrate on our own expertise in core areas, and our HP D300 Digital Dispenser allows us to use our time more effectively, without compromising on results. As a small collaborative research facility we do not have a high enough throughput to effectively use complete laboratory automation systems, but the HP D300 is easy to use and its precision dispensing eliminates the need for tedious manual dilutions. Digital titration also offers several key advantages over traditional manual protocols in terms of reducing waste of valuable compounds, limiting the DMSO content for sensitive assays and increasing reproducibility, but it is the staff time it creates that is most important, liberating skilled individuals to perform more exploratory research. It also allows us to limit the number of variables in a way that would not be possible manually, helping us to rapidly characterize novel biological activities which might otherwise be missed.”


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,100+ scientific posters on ePosters
  • More than 4,500+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Phenomenex,Tecan Partner
Phenomenex, Inc. and the Tecan Group has announced a collaboration to co-market automated solid phase extraction (SPE) sample preparation solutions.
Wednesday, September 09, 2015
Too Gracious a Host
Scientists at the University of Toronto are using Tecan’s Infinite M200 PRO and Gas Control Module to study host-pathogen interactions for Legionella bacteria.
Monday, October 07, 2013
Investigating Protein Targets and Cellular Pathways in Yeasts
Scientists at the Donnelly Centre for Cellular and Biomolecular Research have chosen generations of Tecan microplate readers to monitor the effects of environmental or drug perturbation on molecularly barcoded yeasts.
Monday, October 07, 2013
A Watchful Eye on Biosecurity
Intended for government laboratory and pharmaceutical screening applications, BioSentinel now recommends the Infinite F500 to all its customers.
Monday, October 07, 2013
The Tecan-Fudan University Demo Lab opens in Shanghai
Tecan and Fudan University in Shanghai have joined forces to open a demonstration laboratory in the University’s School of Pharmacy.
Monday, June 24, 2013
Tecan Shows Ongoing Commitment to Clinical and Research Markets in China
Key opinion leaders from major hospital clinical laboratories in China recently visited Tecan’s European research and development centers.
Monday, June 24, 2013
Tecan and Covaris co-market Freedom EVO® with Adaptive Focused Acoustics™
The joint offering will be available to customers for sample preparation, compound management and next generation sequencing applications.
Friday, November 19, 2010
Tecan Group and Luminex Corporation Partner to Develop Automated Newborn Screening Solution
New solution combines multiplexing and automation technologies to create novel system for newborn screening laboratories.
Friday, October 15, 2010
Tecan Provides Automated Solutions for Molecular Pharmacology
Leibniz-Institut uses Tecan’s Freedom EVO® workstations for systematic high throughput screening of bioactive small molecule libraries.
Tuesday, July 06, 2010
Screening Center Chooses Tecan for Reliability and Support
The University of Chicago’s CSC is using Tecan’s Freedom EVO® workstations to provide high throughput cell screening services.
Friday, June 11, 2010
Tecan Collaborates with Arizona State University to Rapidly Assess Radiation Exposure
ASU to develop the Integrated Biodosimetry System to measure an individual’s level of exposure to radiation in the event of a radiological or nuclear incident.
Tuesday, May 04, 2010
Screening Center Chooses Tecan for Support
The University of Chicago utilizes Tecan’s Freedom EVO® workstations to provide high throughput cell screening services.
Monday, August 10, 2009
Robotics and Proteomics: A Promising Partnership for Biomarker Discovery
CLIPP scientists use two of Tecan’s Freedom EVO® platforms to automate sample preparation for a biomarker discovery project.
Thursday, July 23, 2009
Tecan and Pion Expand Collaboration to Develop Automated Drug Screening Solutions
The new automated application provides scalability from an entry-level manual system to a fully automated system with medium or high throughput.
Thursday, July 16, 2009
Tecan and Technoclone; a Collaboration for the University Children’s Hospital in Zurich
Collaboration to validate the TECHNOTHROMBIN® thrombin generation assay for Tecan’s Infinite® M200 multimode microplate reader.
Friday, May 08, 2009
Scientific News
Advancing Protein Visualization
Cryo-EM methods can determine structures of small proteins bound to potential drug candidates.
Breast Cancer Drug Hope
A drug for breast cancer that is more effective than existing medicines may be a step closer thanks to new research.
Harnessing Nature’s Vast Array of Venoms for Drug Discovery
Scripps scientists have developed a method for rapidly identifying venoms.
A New Platform for Discovering Antibiotics
Harvard chemists hope to shorten time, difficulty in measuring their effectiveness, potential.
The Need for Speed
Evaluating MALDI-TOF as a high-throughput screening technology for the pharmaceutical industry.
Antarctic Sponge Extract Kills MRSA
New findings may provide opportunity for developing new drugs to fight dangerous bacteria currently highly resistant to treatment.
US-India Collab Finds Molecular Signatures of Severe Malaria
Study may be a significant advancement in understanding the causes of severe malaria.
Novel Way to Prevent Deadly Bacterial Infections
Monash scientists may have found a way to stop deadly bacteria from infecting patients. The discovery could lead to a whole new way of treating antibiotic-resistant “superbugs”
Gene Expression Controls Revealed
Researchers have modelled every atom in a key part of the process for switching on genes, revealing a whole new area for potential drug targets.
An Old-New Weapon Against Emerging Chikungunya Virus
Researchers utilize existing drugs to interfere with host factors required for replication of Chikungunya virus.
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,100+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,500+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!